- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01734317
An Open Single-centre Investigation Evaluating Efficacy in Second Degree Partial Thickness Burns Using a Silicone Contact Layer Containing Silver.
An Open, Non Controled, Single-centre, Clinical Investigation to Evaluate Efficacy in Second Degree (Superficial, Deep or Mixed) Partial Thickness Burns When Using a Soft Silicone Wound Contact Ayer Containing Silver.
Study Overview
Detailed Description
Approximately 10 subjects from one site will be evaluated provided they fulfill the inclusion criteria and none of the exclusion criteria and gives a signed and dated consent.
Subjects may have sustained a burn injury covering 1-25% of the Total Body Surface Area (TBSA)and assessed as superficial partial-thickness or superficial deep-partial thickness in dept. Each subject will be followed one time per week for a maximum of 3 weeks or until the burn is healed if that occurs earlier. Healing is defined as ≥95% epithelialisation. Percent (%) healed epithelialization will be measured by photo analysing using the PictZar program. Dressing changes will be performed at each visit and in between if deemed necessary by the investigator.Gauze rolls and compression will be used as secondary dressing.All dressing changes will be registered in a log. Pain before, during and after removal will be assessed.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Florida
-
Tampa, Florida, United States, 33606
- Florida Gulf-to-Bay Anesthesiology
-
-
New York
-
Garden City, New York, United States, 11530
- Long Island Plastic Surgical Group, P.C
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Subject with a second degree (superficial, deep or mixed) partial thickness burn from 1-25% TBSA.
- One single, isolated burn area selected for study site Study site area should be between 1-15% BSA
- Male or female
- From 18 years and above
- Either in- or out-patient
- Thermal burn injury
- Signed Informed Consent/Assent Form
Exclusion Criteria:
- Electrical, chemical burn etiology
- If any full thickness areas are present, these should not be > 5 %
- Burn greater than 36 hrs old
- Burns to face
- Use of chemical/enzymatic and biological debridement within 7 days of investigation start
- Presence of inflammation or infection in burn wounds
- Use of topical antibiotics, antiseptics, or antimicrobials in conjunction with study product.
- Subjects with lung injury or Subject being on a ventilator
- Subjects with dermatologic skin disorders or necrotizing processes
- Subjects with insulin dependent diabetes mellitus judged by the investigator to be a potential interference in the treatment
- Diagnosed underlying disease(s) (e.g HIV/AIDS, cancer and severe anaemia) judged by the investigator to be a potential interference in the treatment
- Subject not expected to follow the investigation procedures
- Subjects previously included in this investigation
- Subjects included in other ongoing clinical investigation at present or during the past 30 days
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Dressing
Mepilex Transfer Ag is a soft silicone wound contact layer that absorbs and transfers exudate, maintains a moist wound healing environment and has antimicrobial properties.
|
A soft silicone wound contact layer.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Participants With Wound Healing
Time Frame: 14 days and 21 days
|
Healing at day 14 pt 21.
Healing was defined as ≥95% epithelialisation.
The PictZar program will be used to analyze burn wound healing by tissue type.
("The PictZar equipment for this analysis will be located at MHC HQ, however, the analysis will be performed by a clinician not affiliated with MHC.")
Each subject was followed/assessed one time per week for a maximum of 3 weeks or until the burn was healed if that occured earlier.
|
14 days and 21 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Baseline (Visit 1) Pain Will be Measured Before Burn Assessment Visit 2-3, Pain Will be Measured (Pain BEFORE Dressing Removal, DURING Dressing Removal, AFTER Dressing Removal, 30 Min After Removal
Time Frame: After 0/14/21 days treatment
|
Pain will be measured by using the VAS scale, by placing a vertical mark across the 100 mm long horizontal line, from No pain to the left to Most intense pain imaginable to the right. Baseline (Visit 1) Pain will be measured before burn assessment Visit 2-4, Pain will be measured (Pain BEFORE dressing removal, DURING dressing removal, AFTER dressing removal, 30 min after removal |
After 0/14/21 days treatment
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Hans Schweiger, MD, Florida Gulf-toBay Anesthesiology, Tampa Bay Circle
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- MxT Ag 02
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Wound Healing
-
University of Witten/HerdeckeKCI Europe Holding B.V.CompletedImpaired Wound Healing | Wound Healing Disorder | Abdominal Wound Healing Disorder | Abdominal Wound Healing Impairment | Acute Postsurgical Subcutaneous WoundBelgium, Germany
-
Universidade Estadual Paulista Júlio de Mesquita...RecruitingWound Healing | Palate; WoundBrazil
-
First Affiliated Hospital, Sun Yat-Sen UniversityRecruiting
-
3MRecruiting
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Riyadh Elm UniversityUnknown
-
Icahn School of Medicine at Mount SinaiTerminated
-
OcuNexus Therapeutics, Inc.Completed
-
Stratpharma AGUniversity Hospital, GenevaCompleted
-
Johnson & Johnson Consumer Inc. (J&JCI)CompletedWound HealingUnited States
Clinical Trials on Mepilex Transfer Ag
-
Molnlycke Health Care ABCompleted
-
Molnlycke Health Care ABCompletedDonor Site ComplicationUnited States
-
Molnlycke Health Care ABCompleted
-
Molnlycke Health Care ABCompletedBurn Injury | Skin GraftUnited States
-
Molnlycke Health Care ABCompletedVenous Leg Ulcers | Mixed Leg UlcersFrance, Germany, Netherlands, Czech Republic
-
The University of Texas Medical Branch, GalvestonWithdrawnPartial-thickness BurnUnited States
-
Stedical Scientific, Inc.RecruitingThermal BurnUnited States
-
Aubrey Inc.TerminatedBurn SurgeryUnited States
-
MiMedx Group, Inc.TerminatedTreatment of Partial Thickness BurnsUnited States
-
Molnlycke Health Care ABCompleted